1. Home
  2. ATYR vs NREF Comparison

ATYR vs NREF Comparison

Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • NREF
  • Stock Information
  • Founded
  • ATYR 2005
  • NREF 2019
  • Country
  • ATYR United States
  • NREF United States
  • Employees
  • ATYR N/A
  • NREF N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • NREF Real Estate Investment Trusts
  • Sector
  • ATYR Health Care
  • NREF Real Estate
  • Exchange
  • ATYR Nasdaq
  • NREF Nasdaq
  • Market Cap
  • ATYR 228.1M
  • NREF 265.1M
  • IPO Year
  • ATYR 2015
  • NREF 2020
  • Fundamental
  • Price
  • ATYR $2.98
  • NREF $17.05
  • Analyst Decision
  • ATYR Strong Buy
  • NREF Hold
  • Analyst Count
  • ATYR 4
  • NREF 3
  • Target Price
  • ATYR $19.25
  • NREF $13.75
  • AVG Volume (30 Days)
  • ATYR 877.6K
  • NREF 42.6K
  • Earning Date
  • ATYR 11-07-2024
  • NREF 10-31-2024
  • Dividend Yield
  • ATYR N/A
  • NREF 11.71%
  • EPS Growth
  • ATYR N/A
  • NREF N/A
  • EPS
  • ATYR N/A
  • NREF 1.32
  • Revenue
  • ATYR $235,000.00
  • NREF $73,164,000.00
  • Revenue This Year
  • ATYR N/A
  • NREF N/A
  • Revenue Next Year
  • ATYR $2,057.69
  • NREF $31.45
  • P/E Ratio
  • ATYR N/A
  • NREF $12.90
  • Revenue Growth
  • ATYR N/A
  • NREF 224.04
  • 52 Week Low
  • ATYR $1.14
  • NREF $12.63
  • 52 Week High
  • ATYR $3.80
  • NREF $17.27
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 49.97
  • NREF 69.39
  • Support Level
  • ATYR $2.81
  • NREF $16.42
  • Resistance Level
  • ATYR $3.80
  • NREF $16.89
  • Average True Range (ATR)
  • ATYR 0.25
  • NREF 0.52
  • MACD
  • ATYR -0.08
  • NREF 0.13
  • Stochastic Oscillator
  • ATYR 17.17
  • NREF 91.02

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

Share on Social Networks: